Market News

Susquehanna analyst Christopher Stathoulopoulos maintains Allegiant Travel (NASDAQ:ALGT) with a Neutral and raises the price target from $85 to $13...

NVR (NVR) has come into focus after authorizing a large share repurchase program and joining multiple Russell growth indices, a combination that puts ...

The collaboration brings together two critical building blocks of successful ecommerce: trusted, complete product content and easy to launch, branded ...

Recent bullish research updates on Intel (INTC) have centered on three themes: rising AI infrastructure demand, early traction in foundry services, an...

NVIDIA (NVDA) has announced a change in a key leadership role, with long-serving executive Ajay K. Puri planning to retire and former Microsoft sales ...

Susquehanna analyst Christopher Stathoulopoulos maintains American Airlines Group (NASDAQ:AAL) with a Positive and raises the price target from $16...

Blackstone stock reacts to multi-index value benchmark additions Blackstone (BX) has been added to several Russell value benchmarks, including the Rus...

High yields often hide costly REIT mistakes. Management alignment matters more than cheap valuations. Too much leverage can turn setbacks into disaste...

HC Wainwright & Co. analyst Robert Burns reiterates Telix Pharmaceuticals (NASDAQ:TLX) with a Buy and maintains $20 price target.

HCA Healthcare, Inc. (NYSE:HCA) is one of the best medical care facilities stocks to buy according to analysts. The company ranks tenth on the list, w...

Baird analyst David Koning maintains Visa (NYSE:V) with a Outperform and raises the price target from $370 to $412.

Initial exploration has defined a >35km² ring-shaped magnetic anomaly exceeding 6.5km along its major axis, while shallow drilling has confirmed ra...

Wolfe Research analyst Emmanuel Rosner initiates coverage on Ferrari (NYSE:RACE) with a Outperform rating.

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with r...

Baird analyst David Koning maintains Mastercard (NYSE:MA) with a Outperform and raises the price target from $660 to $680.

Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease ...

onsemi’s Fab Right manufacturing strategy focuses on continuous optimization of manufacturing footprint and directs resources to the most competitive,...

Companies Reporting Before The Bell Companies Reporting After The Bell • Kura Sushi USA (NASDAQ:KRUS) is expected to report quarterly loss at $0.03 pe...

Baird analyst David Koning maintains Genpact (NYSE:G) with a Neutral and lowers the price target from $45 to $38.

AMD stock drops 4% premarket amid tech sector pullback. Is this a buying opportunity? Get the latest AMD market analysis.